BB Biotech 2nd Line Ord Shs (BBZA) – Aktiekurs og nyheder

StartBBZA • FRA

BB Biotech 2nd Line Ord Shs

39,15 €

18. okt., 22.59.47 GMT+2 · EUR · FRA · Ansvarsfraskrivelse

AktieVærdipapir børsnoteret i DEHovedkvarter i CH

Seneste lukkekurs

39,95 €

Dagsinterval

39,05 € - 40,20 €

Årsinterval

36,70 € - 52,60 €

Markedsværdi

2,07 mia. CHF

Gns. volumen

3,69 t

P/E-værdi

Udbytteprocent

Primær børs

SWX

Markedsnyheder

The Motley Fool

for 5 timer siden

The S&P 500 Just Did This for the First Time in 13 Years. Here's What History Says Happens Next.

The relentless stock market rally could pull off another shocker

This Hot Tech Stock Just Knocked Tesla Out Of The S&P 500 Magnificent Seven. Should You Be Buying?

Business Insider

for 18 timer siden

Economist Who Called '08 Recession Warns Stocks in 'Mega-Bubble'

These 6 charts suggest caution as the S&P 500 hits 47th record high of 2024

US SEC gives green light for options listing for spot bitcoin ETFs to NYSE

BTC / USD

0,33 %

BB Biotech AG is a Swiss investment company in the field of biotechnology. The company invests mainly in the United States and Western Europe and is managed by Bellevue Asset Management, a division of Bellevue Group, which is listed on the Swiss Stock Exchange. It is one of the largest investment companies in the biotech sector. Wikipedia

Grundlagt

9. nov. 1993

Hovedkvarter

Küsnacht Zürich
Schweiz

Website

bbbiotech.ch